Robert Lane
Concepts (467)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fetal Growth Retardation | 50 | 2019 | 52 | 12.470 |
Why?
| Epigenesis, Genetic | 29 | 2022 | 83 | 7.860 |
Why?
| Animals | 93 | 2023 | 628 | 5.560 |
Why?
| Hippocampus | 15 | 2022 | 18 | 5.500 |
Why?
| Placental Insufficiency | 18 | 2012 | 19 | 4.710 |
Why?
| Prenatal Exposure Delayed Effects | 15 | 2022 | 22 | 4.630 |
Why?
| Pregnancy | 67 | 2023 | 249 | 4.520 |
Why?
| Rats | 58 | 2015 | 148 | 3.700 |
Why?
| Animals, Newborn | 30 | 2021 | 52 | 3.130 |
Why?
| Female | 77 | 2023 | 3284 | 3.090 |
Why?
| RNA, Messenger | 39 | 2022 | 129 | 2.980 |
Why?
| Gene Expression Regulation, Developmental | 22 | 2018 | 55 | 2.880 |
Why?
| DNA Methylation | 22 | 2023 | 110 | 2.820 |
Why?
| Rats, Sprague-Dawley | 41 | 2016 | 85 | 2.720 |
Why?
| Male | 51 | 2023 | 3180 | 2.520 |
Why?
| Histones | 15 | 2021 | 30 | 2.350 |
Why?
| Liver | 18 | 2021 | 130 | 2.280 |
Why?
| Brain | 7 | 2018 | 80 | 2.150 |
Why?
| Brain Injuries | 4 | 2014 | 12 | 1.770 |
Why?
| Non-alcoholic Fatty Liver Disease | 2 | 2023 | 22 | 1.770 |
Why?
| Diet, High-Fat | 8 | 2021 | 11 | 1.670 |
Why?
| Receptors, Glucocorticoid | 9 | 2020 | 11 | 1.640 |
Why?
| Insulin-Like Growth Factor I | 9 | 2015 | 16 | 1.570 |
Why?
| Chromatin | 9 | 2015 | 24 | 1.520 |
Why?
| Placental Circulation | 6 | 2009 | 6 | 1.500 |
Why?
| Lung | 7 | 2019 | 74 | 1.500 |
Why?
| Obesity | 9 | 2017 | 123 | 1.460 |
Why?
| Mice | 17 | 2023 | 291 | 1.390 |
Why?
| PPAR gamma | 6 | 2015 | 7 | 1.390 |
Why?
| Disease Models, Animal | 15 | 2019 | 71 | 1.320 |
Why?
| Intra-Abdominal Fat | 3 | 2014 | 5 | 1.300 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 20 | 2012 | 80 | 1.260 |
Why?
| MicroRNAs | 5 | 2021 | 27 | 1.260 |
Why?
| Transcription Factors | 5 | 2015 | 41 | 1.160 |
Why?
| Fetus | 7 | 2015 | 21 | 1.160 |
Why?
| Cholesterol | 2 | 2016 | 11 | 1.120 |
Why?
| Apoptosis | 8 | 2009 | 48 | 1.080 |
Why?
| Tumor Suppressor Protein p53 | 6 | 2010 | 43 | 1.030 |
Why?
| Corticosterone | 8 | 2018 | 8 | 1.030 |
Why?
| Kidney | 4 | 2010 | 89 | 1.000 |
Why?
| Promoter Regions, Genetic | 10 | 2021 | 47 | 0.960 |
Why?
| Gene-Environment Interaction | 4 | 2015 | 11 | 0.920 |
Why?
| Erythropoietin | 2 | 2014 | 19 | 0.900 |
Why?
| Fetal Development | 7 | 2020 | 10 | 0.890 |
Why?
| Humans | 26 | 2022 | 6129 | 0.890 |
Why?
| Dual-Specificity Phosphatases | 4 | 2021 | 4 | 0.880 |
Why?
| Muscle, Skeletal | 5 | 2015 | 16 | 0.860 |
Why?
| Protein Processing, Post-Translational | 2 | 2015 | 8 | 0.830 |
Why?
| Diet, Western | 5 | 2021 | 5 | 0.790 |
Why?
| Microglia | 2 | 2018 | 2 | 0.780 |
Why?
| Uterus | 4 | 2017 | 7 | 0.770 |
Why?
| Adipocytes | 3 | 2017 | 7 | 0.760 |
Why?
| Blotting, Western | 13 | 2014 | 27 | 0.750 |
Why?
| Pulmonary Alveoli | 4 | 2013 | 9 | 0.740 |
Why?
| Mice, Inbred C57BL | 8 | 2021 | 86 | 0.740 |
Why?
| Hypertension | 3 | 2010 | 56 | 0.730 |
Why?
| Maternal Nutritional Physiological Phenomena | 6 | 2016 | 6 | 0.720 |
Why?
| Neural Stem Cells | 2 | 2016 | 7 | 0.720 |
Why?
| Maternal Exposure | 5 | 2020 | 8 | 0.700 |
Why?
| Stress, Physiological | 3 | 2019 | 10 | 0.700 |
Why?
| Tacrolimus Binding Proteins | 1 | 2018 | 2 | 0.700 |
Why?
| Anxiety | 1 | 2018 | 43 | 0.670 |
Why?
| Brain-Derived Neurotrophic Factor | 2 | 2021 | 2 | 0.660 |
Why?
| Retinopathy of Prematurity | 2 | 2017 | 5 | 0.630 |
Why?
| Touch | 3 | 2013 | 4 | 0.630 |
Why?
| Caspases | 3 | 2014 | 4 | 0.620 |
Why?
| Lung Diseases | 3 | 2014 | 26 | 0.620 |
Why?
| Environment | 1 | 2016 | 7 | 0.610 |
Why?
| Brain Chemistry | 4 | 2014 | 7 | 0.600 |
Why?
| Immunohistochemistry | 9 | 2013 | 42 | 0.600 |
Why?
| Receptors, LDL | 1 | 2016 | 2 | 0.600 |
Why?
| Tobacco | 2 | 2014 | 8 | 0.590 |
Why?
| Kidney Glomerulus | 2 | 2009 | 19 | 0.590 |
Why?
| Monosaccharide Transport Proteins | 4 | 2001 | 4 | 0.590 |
Why?
| Probiotics | 1 | 2015 | 8 | 0.570 |
Why?
| Oxygen | 4 | 2017 | 14 | 0.570 |
Why?
| Microbiota | 1 | 2015 | 9 | 0.570 |
Why?
| Smoking | 2 | 2014 | 67 | 0.560 |
Why?
| DNA Primers | 9 | 2011 | 37 | 0.560 |
Why?
| Cell Differentiation | 3 | 2013 | 37 | 0.560 |
Why?
| Genome, Human | 1 | 2015 | 73 | 0.540 |
Why?
| Gene Expression | 7 | 2012 | 57 | 0.540 |
Why?
| Hyperinsulinism | 2 | 2013 | 2 | 0.530 |
Why?
| Insulin Resistance | 1 | 2014 | 10 | 0.530 |
Why?
| Docosahexaenoic Acids | 2 | 2013 | 3 | 0.520 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenases | 2 | 2014 | 2 | 0.520 |
Why?
| Hypercholesterolemia | 1 | 2014 | 10 | 0.510 |
Why?
| Social Environment | 1 | 2014 | 10 | 0.500 |
Why?
| Placenta | 4 | 2017 | 14 | 0.500 |
Why?
| Cognition | 1 | 2014 | 29 | 0.500 |
Why?
| Epigenomics | 1 | 2014 | 25 | 0.500 |
Why?
| Methyl-CpG-Binding Protein 2 | 2 | 2011 | 2 | 0.490 |
Why?
| RNA, Long Noncoding | 1 | 2013 | 12 | 0.490 |
Why?
| Chromatin Immunoprecipitation | 6 | 2012 | 10 | 0.480 |
Why?
| Oxygen Inhalation Therapy | 1 | 2013 | 3 | 0.480 |
Why?
| Poverty Areas | 1 | 2013 | 6 | 0.480 |
Why?
| Estradiol | 1 | 2013 | 4 | 0.480 |
Why?
| Estrogen Receptor alpha | 1 | 2013 | 6 | 0.480 |
Why?
| Developing Countries | 1 | 2013 | 13 | 0.480 |
Why?
| General Surgery | 1 | 2013 | 20 | 0.480 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2011 | 18 | 0.470 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 2 | 2010 | 2 | 0.470 |
Why?
| Base Sequence | 8 | 2010 | 77 | 0.460 |
Why?
| Dietary Fats | 3 | 2012 | 8 | 0.460 |
Why?
| Environmental Exposure | 1 | 2012 | 27 | 0.450 |
Why?
| Precision Medicine | 1 | 2012 | 32 | 0.440 |
Why?
| Phosphorylation | 6 | 2017 | 26 | 0.440 |
Why?
| Receptor, ErbB-2 | 1 | 2012 | 4 | 0.440 |
Why?
| Exons | 6 | 2015 | 37 | 0.440 |
Why?
| Dual Specificity Phosphatase 1 | 1 | 2011 | 1 | 0.430 |
Why?
| Thymus Gland | 1 | 2011 | 3 | 0.430 |
Why?
| Proto-Oncogene Proteins | 4 | 2018 | 16 | 0.420 |
Why?
| T-Lymphocytes | 1 | 2011 | 31 | 0.420 |
Why?
| Subcutaneous Fat | 2 | 2013 | 3 | 0.420 |
Why?
| Body Weight | 6 | 2018 | 53 | 0.410 |
Why?
| Elastin | 1 | 2011 | 1 | 0.410 |
Why?
| Vascular Endothelial Growth Factor A | 2 | 2019 | 8 | 0.400 |
Why?
| Up-Regulation | 4 | 2016 | 26 | 0.400 |
Why?
| Histone-Lysine N-Methyltransferase | 1 | 2010 | 10 | 0.400 |
Why?
| Nuclear Proteins | 2 | 2015 | 37 | 0.400 |
Why?
| Aromatase | 1 | 2010 | 1 | 0.400 |
Why?
| Sex Factors | 6 | 2015 | 76 | 0.390 |
Why?
| Myocardium | 2 | 2018 | 7 | 0.390 |
Why?
| Stress, Psychological | 3 | 2018 | 36 | 0.390 |
Why?
| Serine | 2 | 2007 | 4 | 0.390 |
Why?
| Signal Transduction | 3 | 2013 | 94 | 0.380 |
Why?
| Pulmonary Artery | 2 | 2021 | 11 | 0.380 |
Why?
| Mitochondria, Muscle | 2 | 2001 | 2 | 0.380 |
Why?
| Hypertension, Pulmonary | 2 | 2021 | 9 | 0.380 |
Why?
| Adaptation, Physiological | 1 | 2009 | 4 | 0.380 |
Why?
| Transcription, Genetic | 4 | 2015 | 44 | 0.380 |
Why?
| Infant, Newborn | 7 | 2014 | 809 | 0.360 |
Why?
| Proto-Oncogene Proteins c-mdm2 | 2 | 2006 | 14 | 0.360 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 2009 | 1 | 0.360 |
Why?
| Metabolic Diseases | 1 | 2009 | 13 | 0.360 |
Why?
| Research Support as Topic | 2 | 2008 | 6 | 0.350 |
Why?
| Adipogenesis | 1 | 2008 | 1 | 0.350 |
Why?
| Real-Time Polymerase Chain Reaction | 3 | 2014 | 35 | 0.340 |
Why?
| Fatty Acids | 2 | 2014 | 4 | 0.340 |
Why?
| Mentors | 1 | 2008 | 3 | 0.330 |
Why?
| DNA | 2 | 2005 | 39 | 0.330 |
Why?
| Infant, Premature | 3 | 2014 | 84 | 0.330 |
Why?
| Faculty, Medical | 1 | 2008 | 3 | 0.330 |
Why?
| Age Factors | 3 | 2016 | 211 | 0.330 |
Why?
| Analysis of Variance | 4 | 2016 | 26 | 0.330 |
Why?
| Ileum | 2 | 2004 | 18 | 0.320 |
Why?
| High-Frequency Ventilation | 3 | 2013 | 7 | 0.320 |
Why?
| Cyclooxygenase 2 | 1 | 2007 | 6 | 0.310 |
Why?
| Cerebral Cortex | 2 | 2010 | 8 | 0.310 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2006 | 2 | 0.300 |
Why?
| Time Factors | 3 | 2014 | 241 | 0.300 |
Why?
| Nucleosomes | 3 | 2015 | 3 | 0.300 |
Why?
| Phosphoproteins | 1 | 2006 | 12 | 0.300 |
Why?
| Gene Expression Profiling | 3 | 2013 | 91 | 0.300 |
Why?
| bcl-2-Associated X Protein | 5 | 2010 | 6 | 0.300 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2010 | 9 | 0.300 |
Why?
| Inflammation | 2 | 2017 | 45 | 0.280 |
Why?
| Adipose Tissue | 3 | 2015 | 30 | 0.280 |
Why?
| Transcriptome | 2 | 2023 | 40 | 0.280 |
Why?
| RNA | 3 | 2012 | 17 | 0.280 |
Why?
| Nerve Tissue Proteins | 3 | 2013 | 25 | 0.280 |
Why?
| Pediatrics | 1 | 2008 | 173 | 0.280 |
Why?
| Neurons | 2 | 2005 | 10 | 0.280 |
Why?
| Chromatin Assembly and Disassembly | 2 | 2015 | 5 | 0.280 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 2 | 2017 | 3 | 0.270 |
Why?
| CpG Islands | 4 | 2014 | 46 | 0.270 |
Why?
| Jejunum | 1 | 2004 | 5 | 0.260 |
Why?
| Biomarkers | 3 | 2014 | 107 | 0.260 |
Why?
| Polymerase Chain Reaction | 6 | 2014 | 84 | 0.260 |
Why?
| Carbon | 1 | 2004 | 1 | 0.260 |
Why?
| Flow Cytometry | 2 | 2016 | 26 | 0.260 |
Why?
| Macaca | 4 | 2012 | 6 | 0.250 |
Why?
| Adiponectin | 3 | 2013 | 6 | 0.250 |
Why?
| Cells, Cultured | 3 | 2021 | 70 | 0.240 |
Why?
| Adiposity | 2 | 2014 | 11 | 0.240 |
Why?
| Muscle Fibers, Skeletal | 1 | 2003 | 2 | 0.240 |
Why?
| Blood Glucose | 6 | 2015 | 54 | 0.240 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 5 | 0.240 |
Why?
| Maternal-Fetal Exchange | 3 | 2020 | 8 | 0.230 |
Why?
| Gene Expression Regulation | 3 | 2017 | 93 | 0.230 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 22 | 0.230 |
Why?
| Genetic Predisposition to Disease | 2 | 2013 | 136 | 0.220 |
Why?
| Amino Acids, Branched-Chain | 1 | 2001 | 1 | 0.220 |
Why?
| Enzymes | 1 | 2001 | 5 | 0.210 |
Why?
| Hypertrophy, Right Ventricular | 1 | 2021 | 1 | 0.210 |
Why?
| Myocytes, Smooth Muscle | 1 | 2021 | 1 | 0.210 |
Why?
| Vascular Remodeling | 1 | 2021 | 2 | 0.210 |
Why?
| Adult | 4 | 2014 | 1121 | 0.210 |
Why?
| Muscle Proteins | 1 | 2001 | 6 | 0.210 |
Why?
| Uterine Artery | 2 | 2012 | 2 | 0.210 |
Why?
| Sheep | 6 | 2021 | 7 | 0.210 |
Why?
| Hypoxia, Brain | 1 | 2001 | 2 | 0.210 |
Why?
| Protein Kinases | 3 | 2007 | 3 | 0.210 |
Why?
| Cell Proliferation | 1 | 2021 | 51 | 0.210 |
Why?
| Somatomedins | 1 | 2021 | 1 | 0.210 |
Why?
| Respiration, Artificial | 1 | 2021 | 16 | 0.210 |
Why?
| Heart Ventricles | 1 | 2021 | 34 | 0.200 |
Why?
| Acetylation | 4 | 2015 | 7 | 0.200 |
Why?
| Mitochondria | 1 | 2000 | 11 | 0.200 |
Why?
| Bronchopulmonary Dysplasia | 2 | 2013 | 41 | 0.190 |
Why?
| Organogenesis | 1 | 2019 | 2 | 0.190 |
Why?
| Magnetic Resonance Imaging | 2 | 2011 | 111 | 0.180 |
Why?
| Pregnancy, Animal | 2 | 2012 | 2 | 0.180 |
Why?
| Lactation | 2 | 2016 | 7 | 0.180 |
Why?
| Disease Susceptibility | 2 | 2012 | 9 | 0.180 |
Why?
| Fibrosis | 1 | 2018 | 5 | 0.180 |
Why?
| Down-Regulation | 2 | 2010 | 14 | 0.180 |
Why?
| Hypothalamo-Hypophyseal System | 1 | 2018 | 1 | 0.170 |
Why?
| Pituitary-Adrenal System | 1 | 2018 | 1 | 0.170 |
Why?
| Behavior, Animal | 1 | 2018 | 2 | 0.170 |
Why?
| Protein Isoforms | 1 | 2018 | 17 | 0.170 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2018 | 2 | 0.170 |
Why?
| Endothelial Cells | 1 | 2018 | 16 | 0.170 |
Why?
| Gestational Age | 4 | 2008 | 65 | 0.170 |
Why?
| Feedback, Physiological | 1 | 2017 | 1 | 0.160 |
Why?
| Absorptiometry, Photon | 3 | 2014 | 19 | 0.160 |
Why?
| Immunoblotting | 2 | 2010 | 13 | 0.160 |
Why?
| Dietary Supplements | 2 | 2014 | 18 | 0.160 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2017 | 16 | 0.160 |
Why?
| Carnitine O-Palmitoyltransferase | 3 | 2004 | 4 | 0.160 |
Why?
| Eating | 2 | 2014 | 31 | 0.160 |
Why?
| Birth Weight | 4 | 2017 | 31 | 0.160 |
Why?
| Protective Agents | 1 | 2017 | 3 | 0.160 |
Why?
| Premature Birth | 1 | 2017 | 5 | 0.160 |
Why?
| Phosphopyruvate Hydratase | 1 | 2016 | 1 | 0.150 |
Why?
| Nestin | 1 | 2016 | 1 | 0.150 |
Why?
| Antigens, CD | 1 | 2016 | 6 | 0.150 |
Why?
| Toll-Like Receptor 9 | 1 | 2016 | 2 | 0.150 |
Why?
| Microfilament Proteins | 1 | 2016 | 12 | 0.150 |
Why?
| Calcium-Binding Proteins | 1 | 2016 | 10 | 0.150 |
Why?
| Animal Nutritional Physiological Phenomena | 1 | 2016 | 1 | 0.150 |
Why?
| Histone Code | 2 | 2018 | 8 | 0.150 |
Why?
| Transferases | 1 | 1996 | 2 | 0.150 |
Why?
| Oxidoreductases | 1 | 1996 | 10 | 0.150 |
Why?
| Isothiocyanates | 1 | 2015 | 1 | 0.140 |
Why?
| Polyphenols | 1 | 2015 | 1 | 0.140 |
Why?
| Disease Resistance | 1 | 2015 | 1 | 0.140 |
Why?
| Fatty Acids, Volatile | 1 | 2015 | 2 | 0.140 |
Why?
| Choline | 1 | 2015 | 3 | 0.140 |
Why?
| Folic Acid | 1 | 2015 | 13 | 0.140 |
Why?
| Resistance Training | 1 | 2015 | 3 | 0.140 |
Why?
| Muscular Atrophy, Spinal | 1 | 2015 | 3 | 0.140 |
Why?
| Molecular Sequence Data | 2 | 2011 | 63 | 0.140 |
Why?
| Nicotine | 1 | 2015 | 12 | 0.140 |
Why?
| DNA Helicases | 1 | 2015 | 5 | 0.140 |
Why?
| Triglycerides | 3 | 2015 | 21 | 0.140 |
Why?
| Bone Development | 2 | 2012 | 6 | 0.140 |
Why?
| Caspase 3 | 3 | 2008 | 6 | 0.130 |
Why?
| Body Composition | 2 | 2014 | 27 | 0.130 |
Why?
| Leptin | 2 | 2013 | 5 | 0.130 |
Why?
| Cholesterol 7-alpha-Hydroxylase | 1 | 2014 | 1 | 0.130 |
Why?
| Bile Acids and Salts | 1 | 2014 | 2 | 0.130 |
Why?
| Food Supply | 1 | 2014 | 11 | 0.130 |
Why?
| Smoke | 1 | 2014 | 1 | 0.130 |
Why?
| Adipokines | 1 | 2014 | 3 | 0.130 |
Why?
| MAP Kinase Signaling System | 2 | 2021 | 6 | 0.130 |
Why?
| In Situ Nick-End Labeling | 2 | 2004 | 3 | 0.130 |
Why?
| Cotinine | 1 | 2014 | 6 | 0.130 |
Why?
| Weight Gain | 1 | 2014 | 22 | 0.130 |
Why?
| Exploratory Behavior | 1 | 2014 | 1 | 0.130 |
Why?
| Hematocrit | 1 | 2014 | 6 | 0.130 |
Why?
| Epoetin Alfa | 1 | 2014 | 4 | 0.130 |
Why?
| Chemically-Induced Disorders | 1 | 2014 | 1 | 0.130 |
Why?
| Nose | 1 | 2013 | 5 | 0.130 |
Why?
| Recombinant Proteins | 1 | 2014 | 47 | 0.130 |
Why?
| Glucocorticoids | 1 | 2014 | 28 | 0.130 |
Why?
| Respiration | 1 | 2013 | 6 | 0.130 |
Why?
| Starvation | 1 | 2013 | 1 | 0.120 |
Why?
| Fetal Nutrition Disorders | 1 | 2013 | 1 | 0.120 |
Why?
| Infant Mortality | 1 | 2013 | 5 | 0.120 |
Why?
| Metabolic Networks and Pathways | 1 | 2013 | 9 | 0.120 |
Why?
| Dose-Response Relationship, Drug | 1 | 2014 | 85 | 0.120 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 10 | 0.120 |
Why?
| Rural Health Services | 1 | 2013 | 3 | 0.120 |
Why?
| Quality Assurance, Health Care | 1 | 2013 | 7 | 0.120 |
Why?
| Infant, Low Birth Weight | 1 | 2013 | 13 | 0.120 |
Why?
| Health Services Needs and Demand | 1 | 2013 | 17 | 0.120 |
Why?
| Morphogenesis | 1 | 2013 | 8 | 0.120 |
Why?
| Respiratory Distress Syndrome, Newborn | 1 | 2013 | 8 | 0.120 |
Why?
| Molecular Biology | 1 | 2013 | 3 | 0.120 |
Why?
| Receptors, Retinoic Acid | 1 | 2013 | 2 | 0.120 |
Why?
| Treatment Outcome | 1 | 2015 | 621 | 0.120 |
Why?
| Fluorescent Antibody Technique | 2 | 2011 | 9 | 0.120 |
Why?
| Thyroid Hormone Receptors beta | 1 | 2012 | 1 | 0.120 |
Why?
| Thyroid Gland | 1 | 2012 | 4 | 0.120 |
Why?
| Sirtuin 1 | 1 | 2012 | 1 | 0.120 |
Why?
| Osteogenesis | 1 | 2012 | 7 | 0.110 |
Why?
| Arsenic | 1 | 2012 | 2 | 0.110 |
Why?
| Stereotaxic Techniques | 1 | 2012 | 1 | 0.110 |
Why?
| Malnutrition | 1 | 2012 | 9 | 0.110 |
Why?
| Oligodendroglia | 1 | 2012 | 1 | 0.110 |
Why?
| Neuregulin-1 | 1 | 2012 | 1 | 0.110 |
Why?
| Astrocytes | 1 | 2012 | 2 | 0.110 |
Why?
| Bone Density | 1 | 2012 | 45 | 0.110 |
Why?
| Ligation | 1 | 2012 | 4 | 0.110 |
Why?
| Microscopy, Fluorescence | 1 | 2012 | 3 | 0.110 |
Why?
| Models, Animal | 2 | 2015 | 7 | 0.110 |
Why?
| Ventilator-Induced Lung Injury | 1 | 2011 | 1 | 0.110 |
Why?
| Bone Resorption | 1 | 2011 | 3 | 0.110 |
Why?
| Insulin | 4 | 2015 | 45 | 0.110 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2011 | 4 | 0.110 |
Why?
| CD4-CD8 Ratio | 1 | 2011 | 1 | 0.110 |
Why?
| Amino Acid Sequence | 1 | 2011 | 26 | 0.110 |
Why?
| Cell Count | 1 | 2011 | 17 | 0.110 |
Why?
| Microvascular Angina | 2 | 2001 | 2 | 0.100 |
Why?
| Elastic Tissue | 1 | 2011 | 1 | 0.100 |
Why?
| Lung Compliance | 1 | 2011 | 1 | 0.100 |
Why?
| Cell Division | 2 | 2008 | 7 | 0.100 |
Why?
| Infant Nutritional Physiological Phenomena | 1 | 2011 | 8 | 0.100 |
Why?
| Maze Learning | 1 | 2010 | 1 | 0.100 |
Why?
| Histone Deacetylases | 2 | 2012 | 3 | 0.100 |
Why?
| Survival Analysis | 1 | 2010 | 37 | 0.100 |
Why?
| NF-kappa B | 1 | 2010 | 11 | 0.100 |
Why?
| Glucose Transporter Type 1 | 2 | 2001 | 2 | 0.100 |
Why?
| Glucose | 2 | 2001 | 20 | 0.100 |
Why?
| Lysine | 2 | 2012 | 5 | 0.100 |
Why?
| Oxidation-Reduction | 2 | 2001 | 11 | 0.100 |
Why?
| Animals, Domestic | 1 | 2009 | 1 | 0.090 |
Why?
| Metabolome | 1 | 2009 | 4 | 0.090 |
Why?
| Infant | 1 | 2014 | 1389 | 0.090 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2009 | 1 | 0.090 |
Why?
| Aging | 2 | 2007 | 33 | 0.090 |
Why?
| Testosterone | 1 | 2009 | 12 | 0.090 |
Why?
| Disease Progression | 1 | 2009 | 95 | 0.090 |
Why?
| Creatinine | 1 | 2009 | 50 | 0.090 |
Why?
| Chronic Disease | 1 | 2009 | 104 | 0.090 |
Why?
| Mesoderm | 1 | 2008 | 2 | 0.090 |
Why?
| Intermittent Positive-Pressure Ventilation | 1 | 2008 | 2 | 0.090 |
Why?
| Heat-Shock Proteins | 1 | 2008 | 4 | 0.090 |
Why?
| Continuous Positive Airway Pressure | 1 | 2008 | 4 | 0.090 |
Why?
| Academic Medical Centers | 1 | 2008 | 10 | 0.080 |
Why?
| Infant, Small for Gestational Age | 1 | 2008 | 2 | 0.080 |
Why?
| Mice, Knockout | 2 | 2021 | 55 | 0.080 |
Why?
| Fellowships and Scholarships | 1 | 2008 | 19 | 0.080 |
Why?
| Phospholipids | 1 | 2007 | 2 | 0.080 |
Why?
| Hyperplasia | 1 | 2007 | 4 | 0.080 |
Why?
| Alzheimer Disease | 1 | 2007 | 2 | 0.080 |
Why?
| Cell Cycle | 1 | 2007 | 10 | 0.080 |
Why?
| Neovascularization, Physiologic | 1 | 2007 | 4 | 0.080 |
Why?
| Receptors, Mineralocorticoid | 1 | 2007 | 1 | 0.080 |
Why?
| Sex Characteristics | 1 | 2007 | 14 | 0.080 |
Why?
| Insulin Receptor Substrate Proteins | 1 | 2006 | 1 | 0.080 |
Why?
| Young Adult | 1 | 2009 | 607 | 0.080 |
Why?
| Pharmacology | 1 | 2006 | 1 | 0.080 |
Why?
| Neonatology | 1 | 2006 | 6 | 0.070 |
Why?
| Risk Assessment | 3 | 2012 | 129 | 0.070 |
Why?
| Zinc | 1 | 2005 | 3 | 0.070 |
Why?
| Molecular Structure | 1 | 2005 | 5 | 0.070 |
Why?
| Case-Control Studies | 2 | 2021 | 129 | 0.070 |
Why?
| Infant, Newborn, Diseases | 1 | 2006 | 34 | 0.070 |
Why?
| Cyclin A | 1 | 2005 | 3 | 0.070 |
Why?
| Cardiovascular Diseases | 2 | 2018 | 49 | 0.070 |
Why?
| United States | 1 | 2008 | 630 | 0.070 |
Why?
| Binding Sites | 2 | 2015 | 26 | 0.070 |
Why?
| DNA, Complementary | 1 | 2004 | 9 | 0.070 |
Why?
| Epidermal Growth Factor | 1 | 2004 | 2 | 0.070 |
Why?
| Cell Nucleus | 1 | 2004 | 7 | 0.070 |
Why?
| Immunoenzyme Techniques | 1 | 2004 | 9 | 0.070 |
Why?
| Homeostasis | 1 | 2004 | 8 | 0.070 |
Why?
| Cystathionine beta-Synthase | 1 | 2004 | 1 | 0.070 |
Why?
| Methionine Adenosyltransferase | 1 | 2004 | 1 | 0.070 |
Why?
| S-Adenosylhomocysteine | 1 | 2004 | 1 | 0.070 |
Why?
| Methionine | 1 | 2004 | 5 | 0.070 |
Why?
| Enzyme Induction | 1 | 2004 | 5 | 0.070 |
Why?
| Reproducibility of Results | 2 | 2015 | 179 | 0.060 |
Why?
| Phenotype | 1 | 2004 | 207 | 0.060 |
Why?
| DNA Modification Methylases | 1 | 2003 | 1 | 0.060 |
Why?
| Enterocolitis, Necrotizing | 1 | 2004 | 70 | 0.060 |
Why?
| Physical Stimulation | 2 | 2013 | 3 | 0.060 |
Why?
| Ketone Oxidoreductases | 1 | 2001 | 1 | 0.050 |
Why?
| Multienzyme Complexes | 1 | 2001 | 1 | 0.050 |
Why?
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2001 | 1 | 0.050 |
Why?
| Angiotensin II | 1 | 2021 | 1 | 0.050 |
Why?
| Vasoconstrictor Agents | 1 | 2021 | 2 | 0.050 |
Why?
| Muscle, Smooth, Vascular | 1 | 2021 | 8 | 0.050 |
Why?
| Glycogen | 1 | 2001 | 1 | 0.050 |
Why?
| Hexokinase | 1 | 2001 | 1 | 0.050 |
Why?
| Neurogenesis | 1 | 2021 | 3 | 0.050 |
Why?
| Glucose Transporter Type 4 | 1 | 2001 | 2 | 0.050 |
Why?
| Organ Size | 1 | 2001 | 14 | 0.050 |
Why?
| In Vitro Techniques | 1 | 2001 | 21 | 0.050 |
Why?
| Malondialdehyde | 1 | 2001 | 1 | 0.050 |
Why?
| Lipid Peroxidation | 1 | 2001 | 1 | 0.050 |
Why?
| Cyclic AMP | 1 | 2001 | 5 | 0.050 |
Why?
| Oxidative Stress | 1 | 2001 | 13 | 0.050 |
Why?
| Acetyl-CoA Carboxylase | 1 | 2001 | 1 | 0.050 |
Why?
| Alcohol Oxidoreductases | 1 | 2001 | 1 | 0.050 |
Why?
| Malonyl Coenzyme A | 1 | 2001 | 1 | 0.050 |
Why?
| 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2001 | 1 | 0.050 |
Why?
| Hyperlipidemias | 1 | 2001 | 7 | 0.050 |
Why?
| DNA, Mitochondrial | 1 | 2000 | 2 | 0.050 |
Why?
| Random Allocation | 1 | 2020 | 8 | 0.050 |
Why?
| Biomedical Research | 2 | 2013 | 20 | 0.050 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 1 | 0.050 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2019 | 2 | 0.050 |
Why?
| Nitric Oxide Synthase | 1 | 2019 | 7 | 0.050 |
Why?
| Glucose Transporter Type 2 | 1 | 1999 | 1 | 0.040 |
Why?
| Tissue Distribution | 1 | 1999 | 10 | 0.040 |
Why?
| DNA-Binding Proteins | 1 | 2018 | 25 | 0.040 |
Why?
| Heart | 1 | 2018 | 14 | 0.040 |
Why?
| Mitochondrial ADP, ATP Translocases | 1 | 1998 | 1 | 0.040 |
Why?
| Glucosephosphate Dehydrogenase | 1 | 1998 | 1 | 0.040 |
Why?
| Proton-Translocating ATPases | 1 | 1998 | 1 | 0.040 |
Why?
| NADH, NADPH Oxidoreductases | 1 | 1998 | 1 | 0.040 |
Why?
| Electron Transport Complex I | 1 | 1998 | 3 | 0.040 |
Why?
| NAD | 1 | 1998 | 3 | 0.040 |
Why?
| Muscle Development | 1 | 1998 | 2 | 0.040 |
Why?
| 3T3-L1 Cells | 1 | 2017 | 1 | 0.040 |
Why?
| Gene Deletion | 1 | 2017 | 13 | 0.040 |
Why?
| Retinal Neovascularization | 1 | 2017 | 1 | 0.040 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 11 | 0.040 |
Why?
| Rhodopsin | 1 | 1996 | 1 | 0.040 |
Why?
| Cattle | 1 | 1996 | 25 | 0.040 |
Why?
| Energy Metabolism | 1 | 1996 | 25 | 0.040 |
Why?
| Reflex | 1 | 2015 | 2 | 0.040 |
Why?
| Muscle Strength | 1 | 2015 | 3 | 0.040 |
Why?
| Human Growth Hormone | 1 | 2015 | 16 | 0.040 |
Why?
| Body Size | 1 | 2015 | 8 | 0.040 |
Why?
| Methylation | 1 | 2015 | 12 | 0.030 |
Why?
| RNA Splicing | 1 | 2015 | 12 | 0.030 |
Why?
| Sp1 Transcription Factor | 1 | 2015 | 2 | 0.030 |
Why?
| Transcription Initiation Site | 1 | 2015 | 2 | 0.030 |
Why?
| RNA Polymerase II | 1 | 2015 | 3 | 0.030 |
Why?
| Thromboxane A2 | 1 | 2015 | 2 | 0.030 |
Why?
| Motor Activity | 1 | 2015 | 34 | 0.030 |
Why?
| Response Elements | 1 | 2014 | 3 | 0.030 |
Why?
| STAT5 Transcription Factor | 1 | 2014 | 4 | 0.030 |
Why?
| Glucose Tolerance Test | 1 | 2014 | 3 | 0.030 |
Why?
| Lipids | 1 | 2014 | 7 | 0.030 |
Why?
| Gene Regulatory Networks | 1 | 2013 | 12 | 0.030 |
Why?
| Circadian Rhythm | 1 | 2013 | 9 | 0.030 |
Why?
| Risk Factors | 1 | 2015 | 392 | 0.030 |
Why?
| Cluster Analysis | 1 | 2013 | 29 | 0.030 |
Why?
| Receptors, Adiponectin | 1 | 2013 | 1 | 0.030 |
Why?
| Hyperoxia | 1 | 2013 | 5 | 0.030 |
Why?
| Hypothalamus | 1 | 2012 | 1 | 0.030 |
Why?
| Iodide Peroxidase | 1 | 2012 | 1 | 0.030 |
Why?
| Thyroid Hormones | 1 | 2012 | 1 | 0.030 |
Why?
| Hypothyroidism | 1 | 2012 | 4 | 0.030 |
Why?
| p300-CBP Transcription Factors | 1 | 2012 | 1 | 0.030 |
Why?
| Catalytic Domain | 1 | 2012 | 5 | 0.030 |
Why?
| COS Cells | 1 | 2012 | 17 | 0.030 |
Why?
| Substrate Specificity | 1 | 2012 | 17 | 0.030 |
Why?
| Mass Spectrometry | 1 | 2012 | 15 | 0.030 |
Why?
| Environmental Monitoring | 1 | 2012 | 7 | 0.030 |
Why?
| Parathyroid Hormone-Related Protein | 1 | 2011 | 2 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2012 | 140 | 0.030 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2012 | 44 | 0.030 |
Why?
| Mutation | 1 | 2012 | 179 | 0.030 |
Why?
| Infant Food | 1 | 2011 | 7 | 0.030 |
Why?
| Weaning | 1 | 2010 | 1 | 0.030 |
Why?
| Child, Preschool | 1 | 2015 | 1465 | 0.020 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2009 | 3 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2009 | 69 | 0.020 |
Why?
| Adolescent | 1 | 2015 | 2015 | 0.020 |
Why?
| Alternative Splicing | 1 | 2009 | 17 | 0.020 |
Why?
| Tidal Volume | 1 | 2008 | 1 | 0.020 |
Why?
| Proliferating Cell Nuclear Antigen | 1 | 2008 | 3 | 0.020 |
Why?
| Pregnancy Outcome | 1 | 2008 | 5 | 0.020 |
Why?
| Reference Values | 1 | 2008 | 38 | 0.020 |
Why?
| Ultrasonography, Doppler | 1 | 2008 | 11 | 0.020 |
Why?
| Child | 1 | 2015 | 3004 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2008 | 302 | 0.020 |
Why?
| Infant, Extremely Low Birth Weight | 1 | 2006 | 10 | 0.020 |
Why?
| Retrospective Studies | 1 | 2008 | 1232 | 0.010 |
Why?
| Blood-Brain Barrier | 1 | 2002 | 2 | 0.010 |
Why?
| Fetal Blood | 1 | 1999 | 5 | 0.010 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|